Carrie J Finno1, Heather J Kaese2, Andrew D Miller3, Giuliana Gianino1, Thomas Divers4, Stephanie J Valberg5. 1. Population Health and Reproduction, School of Veterinary Medicine, School of Medicine, University of California, Davis, CA, 95616, USA. 2. Eye Care for Animals, Lees Summit, MO, 64064, USA. 3. Section of Anatomic Pathology, Department of Biomedical Sciences Medicine, Cornell University College of Veterinary, Ithaca, NY, 14853, USA. 4. Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, 14853, USA. 5. Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48895, USA.
Abstract
OBJECTIVE: A pigment retinopathy has been reported in adult horses with equine motor neuron disease (EMND) arising from chronic α-tocopherol (α-TP) deficiency. A pigment retinopathy has not been identified in horses with neuroaxonal dystrophy/equine degenerative myeloencephalopathy (NAD/EDM) that affects genetically susceptible young horses with α-TP deficiency. The objective of this report is to describe, for the first time, a pigment retinopathy in a family of α-TP-deficient Warmbloods (WB) with clinically apparent NAD/EDM or EMND. ANIMALS AND PROCEDURES: Twenty-five WB horses from one farm underwent complete neurologic and ophthalmic examinations and serum α-TP concentrations were assessed. Two of the most severely ataxic horses were euthanized and postmortem examinations performed. RESULTS: Alpha-TP deficiency was widespread on this farm (22 of 25 horses). Eleven of 25 horses were clinically normal (age range 2-12 years), one had signs of EMND (6 years of age), 10 had signs of ataxia consistent with NAD/EDM (1-10 years), and two of these were postmortem confirmed concurrent NAD/EDM and EMND. A pigment retinopathy characterized by varying amounts of granular dark pigment in the tapetal retina was observed in four clinically apparent NAD/EDM horses (two postmortem confirmed concurrent NAD/EDM and EMND) and one horse with clinical signs of EMND. CONCLUSIONS: A pigment retinopathy can be present in young α-TP-deficient Warmblood horses with clinical signs of EMND as well as those with signs of NAD/EDM.
OBJECTIVE:A pigment retinopathy has been reported in adult horses with equinemotor neuron disease (EMND) arising from chronic α-tocopherol (α-TP) deficiency. A pigment retinopathy has not been identified in horses with neuroaxonal dystrophy/equine degenerative myeloencephalopathy (NAD/EDM) that affects genetically susceptible young horses with α-TP deficiency. The objective of this report is to describe, for the first time, a pigment retinopathy in a family of α-TP-deficient Warmbloods (WB) with clinically apparent NAD/EDM or EMND. ANIMALS AND PROCEDURES: Twenty-five WB horses from one farm underwent complete neurologic and ophthalmic examinations and serum α-TP concentrations were assessed. Two of the most severely ataxichorses were euthanized and postmortem examinations performed. RESULTS:Alpha-TP deficiency was widespread on this farm (22 of 25 horses). Eleven of 25 horses were clinically normal (age range 2-12 years), one had signs of EMND (6 years of age), 10 had signs of ataxia consistent with NAD/EDM (1-10 years), and two of these were postmortem confirmed concurrent NAD/EDM and EMND. A pigment retinopathy characterized by varying amounts of granular dark pigment in the tapetal retina was observed in four clinically apparent NAD/EDMhorses (two postmortem confirmed concurrent NAD/EDM and EMND) and one horse with clinical signs of EMND. CONCLUSIONS:A pigment retinopathy can be present in young α-TP-deficient Warmblood horses with clinical signs of EMND as well as those with signs of NAD/EDM.
Authors: T Yokota; K Igarashi; T Uchihara; K Jishage; H Tomita; A Inaba; Y Li; M Arita; H Suzuki; H Mizusawa; H Arai Journal: Proc Natl Acad Sci U S A Date: 2001-12-18 Impact factor: 11.205
Authors: Carrie J Finno; Monica Aleman; Ron Ofri; Steven R Hollingsworth; John E Madigan; Laramie Winfield; Danika L Bannasch Journal: Vet Ophthalmol Date: 2012-03-20 Impact factor: 1.644
Authors: C J Finno; R J Higgins; M Aleman; R Ofri; S R Hollingsworth; D L Bannasch; C M Reilly; J E Madigan Journal: J Vet Intern Med Date: 2011 Nov-Dec Impact factor: 3.333
Authors: C J Finno; K E Estell; S Katzman; L Winfield; A Rendahl; J Textor; D L Bannasch; B Puschner Journal: J Vet Intern Med Date: 2015-09-22 Impact factor: 3.333
Authors: Erin N Hales; Christina Esparza; Sichong Peng; Anna R Dahlgren; Janel M Peterson; Andrew D Miller; Carrie J Finno Journal: Genes (Basel) Date: 2020-01-10 Impact factor: 4.096